Preparation of an internal whitepaper on pricing and access issues (and potential solutions) for gene therapies

CRA approach

  • Leveraged prior CRA working knowledge and extensive primary and secondary research
  • Whitepaper focused on the following elements:
    • Gene therapy landscape and future pipeline
    • Overcoming pricing challenges via value demonstration
    • Health system/payer/patient affordability issues
    • Triggers for systemic change

Client impact

  • Business development, pricing, and commercialization decisions based on adaptive frameworks and heuristics
Related capabilities